If you want to know who really controls InMode Ltd. (NASDAQ:INMD), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are institutions ...

Canaccord lowered the firm’s price target on InMode (INMD) to $15 from $16 and keeps a Hold rating on the shares. The firm said they are bullish on the Med-Tech sector heading into 2026 as they expect ...

InMode Ltd. remains a global leader in minimally invasive aesthetic medical devices, trading at a deep discount with a net cash position covering 58% of market cap. Despite a sharp 85% drawdown since ...

Fintel reports that on December 17, 2025, Canaccord Genuity maintained coverage of InMode (NasdaqGS:INMD) with a Hold recommendation. Analyst Price Forecast Suggests 18.34% Upside As of December 6, ...

The latest update is out from InMode ( (INMD)). On November 5, 2025, InMode Ltd. announced its financial results for the third quarter of 2025, reporting revenues of $93.2 million, a decrease from ...

Tap into the wealth of resources you’ll need—getting started is easy Lisa Smith is a writer with a passion for financial journalism, contributing to popular media outlets like Investopedia and ...